Unbalanced risk-benefit analysis of ADHD drugs

Erlend G. Faltinsen, Christian Gluud, Erik Simonsen, Morris Zwi, Ole Jakob Storebø

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
TidsskriftThe Lancet Psychiatry
Vol/bind5
Udgave nummer11
Antal sider1
ISSN2215-0366
DOI
StatusUdgivet - 2018

Citer dette

Faltinsen, Erlend G. ; Gluud, Christian ; Simonsen, Erik ; Zwi, Morris ; Storebø, Ole Jakob. / Unbalanced risk-benefit analysis of ADHD drugs. I: The Lancet Psychiatry. 2018 ; Bind 5, Nr. 11.
@article{67db7a9589414f188f9c4583d18db272,
title = "Unbalanced risk-benefit analysis of ADHD drugs",
author = "Faltinsen, {Erlend G.} and Christian Gluud and Erik Simonsen and Morris Zwi and Storeb{\o}, {Ole Jakob}",
year = "2018",
doi = "10.1016/S2215-0366(18)30334-1",
language = "English",
volume = "5",
journal = "The Lancet Psychiatry",
issn = "2215-0366",
publisher = "TheLancet Publishing Group",
number = "11",

}

Unbalanced risk-benefit analysis of ADHD drugs. / Faltinsen, Erlend G.; Gluud, Christian; Simonsen, Erik; Zwi, Morris; Storebø, Ole Jakob.

I: The Lancet Psychiatry, Bind 5, Nr. 11, 2018.

Publikation: Bidrag til tidsskriftLetterForskningpeer review

TY - JOUR

T1 - Unbalanced risk-benefit analysis of ADHD drugs

AU - Faltinsen, Erlend G.

AU - Gluud, Christian

AU - Simonsen, Erik

AU - Zwi, Morris

AU - Storebø, Ole Jakob

PY - 2018

Y1 - 2018

U2 - 10.1016/S2215-0366(18)30334-1

DO - 10.1016/S2215-0366(18)30334-1

M3 - Letter

VL - 5

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

SN - 2215-0366

IS - 11

ER -